2023 SPEAKERS
Harblas Ahir, Global Market Access, MSD
Saad Ahmad, Director of New Business Development, Global Pricing, and Market Access, Market Access Solutions LLC.
David Alderson, Project Director, Strategic Market Access, Cogentia Healthcare Consulting
Omar Ali, Visiting Lecturer, University of Portsmouth
Simon Andrews, Senior Vice President, Head of Analytics, EVERSANA
Luigi Angelillo, Director, Market Access EMEA, Argenx
Ad Antonisse, Director Market Access & External Affairs, AstraZeneca BV
Emanuele Arca, Research Consultant – SMA & PCO, OPEN Health
Fausto Artico, Global R&D Tech Head of Innovation & Data Science, GSK
Marnix Artz, Head of Patient Access, Pricing & Public Affairs, Netherlands, Merck Group
Cecilie Astrup, Health economist, Amgros I/S
Yumi Asukai, Senior Director, Gilead Sciences Ltd
Nico Bacharidis, Chief Commercial Officer, Cube RM
Sumeet Bakshi, Senior Vice President, Real World Evidence, Lifescience Dynamics
Andy Ballantyne, VP Market Access, Ipsos Healthcare
Dorothee Bartels, Associate Professor, Hannover medical school
Fabienne Bartoli, Director-General, French National Authority for Health
Alexander Bastian, VP Value & Market Access, A.M. Pharma
Maeva Bavoux, Consultant, Lifescience Dynamics
Ahmad Bechara, Senior Vice President Global Market Access and Pricing, Alira Health
Catherine Beecher, Partner, Red Nucleus
Tomer Ben Zaken, Head of Sick Funds Access, AbbVie
Nadia Benhadi, Eu Market Access And Pricing Director, GlaxoSmithKline
Nick Besseling, Manager Value Strategies & Agreements, Astrazeneca
Jesper Bjerggren, European Market Access Lead Respiratory/Digital Health, TEVA pharmaceuticals
Marie-Sharmila Blandino, Global Integrated Access Strategy Lead at Amgen and Vice-Chair of EFPIA Oncology Platform, Amgen
Thomas Bols, Head of Government Affairs and Patient Advocacy, PTC Therapeutics
Vidya Breeveld, Founder, Transmineo
Alberto Briones, Senior Consultant, Lifescience Dynamics
Sangeeta Budhia, VP, Pricing & Market Access, Parexel
Rob Burley, Director Of Campaigns, Care And Support, The Muscular Dystrophy U.K.
Astrid Buys, Global Head of Tenders & Pricing, Bavarian Nordic A/S
David Carr, Senior Director of Global Pricing & Market Access, PRECISIONadvisors
Sandro Cesaro, Head of Europe Market Access & Pricing, Astrazeneca
Mark Chalmers, Partner, Life Sciences Commercial Access, EY
Catherine Chamoux, Consultant, Aesara
Mata Charokopou, Global Head of Access, Price & Evidence, UCB
Helene Chevrou-Severac, HEOR RWE Centre of Excellence Head, International & Japan, Alexion – AstraZeneca Rare Disease
Sally Chung, VP, Head of Market Access & Pricing Europe, GSK
Friso Coerts, Market Access & HTA Manager, Pfizer
Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics
Stephen Connell, Director Payer Insights & Access, Pfizer Ltd
Paolo Correale, Senior Principal, Global Pricing & Access Consulting, EVERSANA
Craig Currie, Chief Scientific Officer, Human Data Sciences
Thomas Daniel, Business Development Manager, Vivet Therapeutics
Luca Dellamano, Director Market Access, Fingerpost Consulting
Rossella Di Bidino, HTA expert, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Anna Dickinson, Senior Researcher, Science and Technology, Onward
Toon Digneffe, Head Public Affairs & Public Policy, Takeda
Marcus Droege, Vice President, Global Value & Market Access, Passage Bio
Gilles Ducorroy, Global Head of RWE Services, Novartis
Michael Epstein, Head, Pricing and Commercial Strategy, Ascenian Consulting and Market Research, LLC
Karen Eryou, Head, Industry Engagement, Access to Medicine Foundation
Gina Ewy, VP, Head of Global Market Access, Hansa Biopharma
Stefaan Fiers, Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda
Ana Filipa Fonseca, Global Value & Access Director - Early Assets, Radioligand Therapy, Novartis
Graham Foxon, Managing Director, Remap Consulting
Stefan Franzen, Director, Medical & Payer Evidence Statistics, Astrazeneca
Neil Gallagher, Managing Economist, Copenhagen Economics
Sandra Garitonandía, LS Industry Principal EMEA, Vistex GmbH
Philippe Ghyssels, VP Corporate and Global Public Affairs, IPSEN
Fabrizio Gianfrate, Full Pro. of Health Economics and Outcome Research, University of Ferrara
Ramiro Gilardino, Global HTA & Access Policy Lead, MSD
Thomas Gilboy, Product Owner, Access Infinity
Christoph Glaetzer, Chief Global Value and Access Officer, The Janssen Pharmaceutical Companies of Johnson & Johnson
Denise Globe, Head Global Health Economics and Outcomes Research Center of Excellence, Gilead Sciences
Josie Godfrey, Co-Founder and Chief Executive Officer, Realise Advocacy
Wim Goettsch, Associate Professor of HTA, Utrecht Centre for Pharmaceutical Policy and Regulation
Wyatt Gotbetter, SVP Access Consulting, Parexel
Alicia Granados, Head, Global Rare Diseases Scientific Advocacy, SANOFI
Pina Haberl, Senior Director, Global Market Access, Partners4Access
Gunter Harms, Senior Market Access Director, Novartis Gene Therapies
Sabina Heinz, Senior Principal Market Access, Ipsos Healthcare
Birgit Holz, Global Head of Contracting Innovation, Sanofi
Alison Horsfield, Global Strategy & Innovation Director, AstraZeneca
Francois Houyez, Treatment Information And Access Director, Health Policy Advisor, EURORDIS
Kirsty Hoyle, Chief Executive Officer, Metabolic Support UK
Amy Israel, Policy and Health Systems Executive, Independent
Shrividya Iyer, Executive Director, Global RWE & US HEOR, Eisai
Jayasree Iyer, Chief Executive Officer, Access to Medicine Foundation
Daniel Jackson, Global Head of Market Access Policy, UCB
Saira Jan, Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey
Christel Jansen, Director, Inbeeo
Shalini Jayasekar Zurn, Senior Advocacy Manager, Union for International Cancer Control
Priti Jhingran, VP, Evidence Strategy, Genesis Research
Pall Jonsson, Programme director for Data, National Institute for Health & Care Excellence (NICE)
Madhu Kabra, Global Director HEOR, MKGlobal
Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, Roche
Lisette Kaskens, Director Market Access for Europe, Latam and Canada, Ferring Pharmaceuticals
Nadia Kaskure, Value Strategy Lead, Novo Nordisk
Tom Kelly, Associate Director, Dolon
Francesca Kessler, Analyst, LOGEX B.V.
Jelle Kleijn, Global Head of Acanthamoeba Keratitis, SiFi
Linda klein Holkenborg, Medical Advisor, CZ
Jolanda Koenders, Head Of Patient Value And Access, Takeda
Huib Kooijman, Advisor, EQRx, Inc.
Simone Koole, Medical advisor, ONVZ
Augusta Elizabeth Koroma, Chief Executive Officer, Sickle cell Intervention U.K
Aleksandra Krygiel-Nael, Head of Government Affairs and Policy, Medical Devices, Johnson & Johnson
Maria Kubin, Vice President of Global Market Access, Bayer Healthcare Ag
Hannah Kurth, Market Access and Pricing Expert, Independent
Simon Lande, Chief Executive Officer, HealthLumen
Gael Le Rouzo, Global market access director, EUSA Pharma
Timothy Lenehan, CVP Global Evidence, Pricing and Access, Novo Nordisk
Giovanny Leon, Global Price Affordability & Early Access Executive Director, Novartis AG
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Gavin Lewis, Global Head of Market Access, Amgen
Herve Lilliu, Chief Executive Officer, Inbeeo
Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada
Richard Macaulay, Vice President, PRECISIONadvisors
James Maddocks, International Policy Advisor, NHS Confederation
Victor Maertens, Government Affairs Manager, EUCOPE
Joerg Mahlich, Market Access and Government Affairs Lead, Miltenyi Biomedicine GmbH
Andrea Mantovani, Vice President - Global Market Access & Pricing, Alira Health
Marco Marchetti, Director of Health Technology Assessment Unit, National Agency for Regional Care Services, Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas
Marisca Marian, Market Access Strategy Leader, Bayer
Linda McNamara, Senior Director, Payer Value and Patient Access, Kyowa Kirin GmbH
Susanne Michel, Head, HTA Consulting and Evidence Planning, Ascenian Consulting and Market Research, LLC
Vanessa Mirsky, Senior Director of Corporate Strategy and Global Payer Partnerships, EQRx, Inc.
Rasha Mokaddem, Market Access Director, Johnson & Johnson
Paolo Morgese, Head of Public Affairs, Europe, Alliance for Regenerative Medicine
Tal Morginstin, Director, HTA division, Ministry of Health
Frederik Mortensen, Head of Market Access, Novartis Oncology Netherlands, Novartis
Shri Mukku, Founding Director, Access Infinity Ltd
Andrew Mumford, Chief Executive Officer, Initiate Consultants
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Bertalan Nemeth, Principal Researcher, Syreon Research Instittue
Lisette Nientker, Associate Director, OPEN Health
Enkeleida Nikai-Fitzgerald, Vice President, Global Real-World Evidence (RWE), Global Commercial Data Science, Janssen Pharmaceutical
Esther Nzenza, Chief Executive Officer and Founder, DECISIVE CONSULTING LTD
Andrew Olaye, Head of EMEA Market Access, Orchard Therapeutics Ltd
Melvin Olson, Global Head Integrated Evidence Strategy and Innovation, Novartis
Susanne Osanto, Professor of Oncology, Lumc
Gavin Outteridge, Managing Director - AESARA Europe, Aesara
Mario Ouwens, Group Director Medical & Payer Evidence Statistics, AstraZeneca
Ana Palma, Senior Director Global Head of Patient Access & Access Policy, Sobi
Elena Panitti, Global Head Real World Evidence Excellence, Novartis
Arun Parekkat, European Commercial & UK Country Lead, LOGEX B.V.
Marta Pastor, Economic Senior Consultant, Catalan Health Service
Preeti Patel, Chief Executive Officer and Founder, Global Pricing Innovations (GPI)
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Lara Pippo, Head Of Market Access, Italy, CSL Behring
Sandra Pisek, Head Established Products, Europe, Sandoz
Anke Pisters-van Roy, MD, CZ
Ana Plata, Global Pricing Head, AstraZeneca
Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP
Ludovica Polverino, Market Access Director, Daiichi Sankyo Development Ltd
Fleur Pool, Medical Access Manager, Novartis Pharma B.V. NL
Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche
Nuno Prego Ramos, Chief Executive Officer, cellmabs
Marco Rauland, Vice President Global Market Access & Pricing - Strategic Planning, Merck Group
Laurene Redding, Head, Value, Access & Policy, Canada, BeiGene
Peny Retsa, Market Access and External Relations Director, AbbVie
Maximus Rex, Manager, Inbeeo
Sybille Riou, Global Market Access Manager, Miltenyi Biotec
Mercedes Romano Rodriguez, Senior Global Market Access Manager, ALK
Sandrine Ruiz, Global Market Access Manager, Immunocore Ltd
Rachele Saccon, Engagement Manager, Lifescience Dynamics Ltd
Marcelo Sal, Head of Market Access and Pricing, South Cone of South America, PTC Therapeutics
Steve Sandor, Vice President of Market Access and Trade, Paratek Pharmaceuticals , Inc.
Paci Sandra, Head access europe, Argenx
Andrew Satherley, Joint Managing Director, Lightning Health Ltd
Cathrin Schaefer, Senior Director Market Access, Sub-region Europe, BeiGene
Sophie Schmitz, Managing Partner, Partners4Access
Richard Sear, Director, Dolon
Ayman Semaan, Market Access & Pricing Lead, Biologix and Director of Communication - ISPOR Lebanon Chapter, BIOLOGIX
Hans Severens, Scientific adviser, Severens HTA consultancy
Navin Sewak, Global Market Access Director, ViiV Healthcare
Sandip Shah, Chief Executive Officer, MKTXS
Adelaide Shaw, Market Access Consultant, Initiate Consultants
Simon Shohet, Market Access, Amicus Therapeutics
Maartje Smulders, Sr Director RWE, Astellas
Igor Solev, Global Head of Market Access, Policy & External Payor Affairs, Abbott Laboratories
Edward Stockton, Senior Director: Market Access, Fingerpost Consulting
Helen Stoop, Head of Patient Advocacy – Takeda Europe and Canada, Takeda
Bart Strzelec, Ops Associate, Inbeeo
Fisentzos Stylianou, Senior Analyst, Partners4Access
Teddy Sun, Evidence Generation Lead, Takeda
Jan Swiderski, Public Affairs & Advocacy Director, IPSEN
Iselin Dahlen Syversen, Head of Department New Methods, Sykehusinnkjøp HF
Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation
sameera tak, Operating Director, Aesara
Peter Takacs, Global Business Operations, Miltenyi Biotec B.V. & Co. KG
Sam Taylor, Emerging Markets Strategic Pricing Lead, Pfizer
Chris Teale, SVP Market Access, Ipsos Market Access
Luca Tofani, Director, Pricing and MArket Access, SIFI spa
Richard Tolley, Head of Market Access EU, Ipsos Market Access
Francesca Torelli, Associate Director, Valid Insight
Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health
Ilona Torontali, Global Head Pricing and Reimbursement, Roche
Sheela Upadhyaya, Life Science Advisor in Rare Diseases & Special Advisor, Fipra
Bart Van Den Daele, Head of External Affairs – Director Market Access - Belux, Gilead Sciences
Goedele Van Haasteren, Staff Member, Swiss Federal Office of Public Health
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Medical Advisor, CZ
Lavni Varyani, Founder, Pharma BP DMCC
Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia
Stefan Walzer, General Manager, MArS Market Access & Pricing Strategy, Germany
Jürgen Wasem, Professor for Health Services and Management, University Duisburg Essen
Grace Wayi-Wayi, Global Associate Director - Market Access, Eusa
Lara J Wolfson, Executive Director and Head of Hta Statistics, Merck
Lara J. Wolfson, Exec. Dir., Biostatistics Biostatistics & Res Decision Sciences, MSD
Claire Woon, Agency lead, AMICULUM Access
James Wright, Director, Valid Insight
Natasa Zibelnik, Head of Market Access EMEA - Oncology, Menarini Group
Peter Zimmermann, Sr Director of Global Customer Success, Model N (Switzerland) GmbH
Zinajda Zolic-Karlsson, Senior advisor, Norwegian medicines agency
Zsombor Zrubka, Associate Professor - Department Of Health Economics, Obuda University
Get Involved
Sponsorship & Exhibition Sales
David Boore
david.boore@terrapinn.com
+44 20 8164 3052
Conference Production
George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940
Marketing Opportunities
Diana Cobzac
diana.cobzac@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events